ProductsDistribution Products

REPLENINE – VF 1000

Therapeutic indication:

Treatment and prophylaxis of bleeding in patients with hemophilia B (congenital factor IX deficiency).

  • Composition: Factor II 0.2 IU/ml, Factor IX 50 IU/ml, Factor X 1 IU/ml
  • Pharmaceutical form: Powder for solution for injection
  • Method of administration: Intravenous
  • Manufacturer: Bio Products Laboratory Limited (BPL)

Join Our Mailing List

Sign up to receive Email updates from Kamada

Latest News

Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability
Mar. 6, 2024